1 |
Zhang FL, Lin HS, He QY. Effect of electro-acupuncture in treating morphine sulfate caused constipation in tumor patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29(10):922-925, 2009
|
2 |
Zhu HD, Gong Z, Hu BW, Wei QL, Kong J, Peng CB. The efficacy and safety of transcutaneous acupoint interferential current stimulation for cancer pain patients with opioid-induced constipation: A prospective randomized controlled study. Integr Cancer Ther 17(2):437-443, 2018
DOI
|
3 |
Cai H, Zhou Q, Bao G, Kong X, Gong LY. Transcutaneous electrical nerve stimulation of acupuncture points enhances therapeutic effects of oral lactulose solution on opioid-induced constipation. J Int Med Res 47(12):6337-6348, 2019
DOI
|
4 |
Markland AD, Palsson O, Goode PS, Burgio KL, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 108(5):796-803, 2013
DOI
|
5 |
Yang J, Wang HP, Zhou L, Xu CF. Effect of dietary fiber on constipation: A meta analysis. World J Gastroenterol 18(48):7378-7383, 2012
DOI
|
6 |
Park JU, Byun JI, Jung SH, Son IJ, Lee HS. Prophylactic laxative use and the compliance in relation to opioid-induced constipation. J Kor Soc Health-Syst Pharm 28(2):136-141, 2011
DOI
|
7 |
Wickham RJ. Managing Constipation in Adults With Cancer. J Adv Pract Oncol 8(2):149‐161, 2017
|
8 |
Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ. Methylnaltrexone treatment of opioid-induced constipation in patients with advanved illness. J Pain Symptom Manage 38(5):683-690, 2009
DOI
|
9 |
Cho NH, Ryu BH. A study on Constipation. Korean J Orient Int Med 21(1):169-180, 2000
|
10 |
Jeon CH, Cho CS. Postoperative adhesive small bowel obstruction treated using acupuncture and moxibustion: A case report. Korean J Orient Int Med 41(2):233-240, 2020
DOI
|
11 |
Lee JY, Moon YJ, Chae HN, Moon G, Kwon YM, Baek DG. Two case reports using herbal medicine for long-term chronic constipation patients who take laxatives. Korean J Orient Int Med 39(5):1052-1060, 2018
DOI
|
12 |
Lamas K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C. Effects of abdominal massage in management of constipation-a randomized controlled trial. Int J Nurs Stud 46(6):759-767, 2009
DOI
|
13 |
Oh SD, Lim SM, Shin HS, Baek ET, Kim YT, Ra SY. The clinical review of bowel disorders following Parkinson's disease. Korean J Orient Int Med 22(4):735-742, 2001
|
14 |
Kang YL, Kim YJ, Hwang CW. The clinical study on 45 cases of patients of constipation caused by C.V.A who were treated with Bo-Riu Enema. Korean J Orient Int Med 21(2):329-336, 2000
|
15 |
Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician 11(2):S105-S120, 2008
|
16 |
Kim JH, Song H, Lee GW, Kang JH. Opioid withdrawal symptoms after conversion to oral oxycodone/naloxone in advanced cancer patients receiving strong opioids. Korean J Hosp Palliat Care 20(2):131-135, 2017
DOI
|
17 |
Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin 21(10):1555-1566, 2005
DOI
|
18 |
McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. Management of opioid side effects in cancer-related and chronic noncancer pain-A systematic review. J Pain 4(5):231-256, 2003
DOI
|
19 |
Hong KS, Jung KW, Lee TH, Lee BE, Park SY, Shin JE, Kim SE, Park KS, Choi SC. Current issudes on the treatment of chronic constipation. Korean J Gastroentero 64(3):148-153, 2014
DOI
|
20 |
Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017
DOI
|
21 |
Boland JW, Boland, EG. Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ 358:J3313. 2017. DOI:10.1136/bmj.j3313
DOI
|
22 |
Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017
DOI
|
23 |
Larkin PJ, Cherny NI, La Carpia D, et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(4):111-125, 2018
|
24 |
Jeon HH, Park HJ. Diagnosis and treatment of constipation. Korean J Med 83(5):568-579, 2012
DOI
|
25 |
Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag 5(3):137-144. 2009
DOI
|
26 |
Gatti A, Sabato AF. Management of Opioid-Induced Constipation in Cancer Patients. Clin Drug Investig 32:293-301, 2012
DOI
|
27 |
LoCasale RJ, Datto CJ, Margolis MK, Tack J, Coyne KS. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use. Int J Clin Pract. 69(12):1448-1456, 2015
DOI
|
28 |
Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 44(8):1201-1209, 2001
DOI
|
29 |
Agra Y, Sacristan A, Gonzalez M, Ferrari M, Portugues A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage 15(1):1-7, 1998
DOI
|
30 |
Ahmedzai, SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid 2010:2407, 2010
|
31 |
Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 11(4):575-581, 2008
DOI
|
32 |
Pitlick M, Fritz D. Evidence about the pharmacological management of constipation, part 2: implications for palliative care. Home Healthc Nurse 31(4):207-218, 2013
DOI
|
33 |
Selby W, Corte C. Managing constipation in adults. Aust Prescr 33:116-119, 2010
DOI
|
34 |
Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Zuurmond WWA. The management of constipation in pallative care: Clinical practice recommendations. Palliat Med 22(7):796-807, 2008
DOI
|
35 |
Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid induced constipation in advanced illness. N Engl J Med 358(22):2332-2343, 2008
DOI
|
36 |
National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 1. Fort Washington, PA: National Comprehensive Cancer Network; c2020. 2020 for Pallative care [cited 2020 Oct 19]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf
|
37 |
Siemens W, Becker G. Methylnaltrexone for opioid-induced constipation : Review and meta-analyses for objective plus subjective efficacy and safety outcomes. Ther Clin Risk Manag 12:401-412, 2016
DOI
|
38 |
Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 35(5):458-468, 2008
DOI
|
39 |
Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 7(1):39-46, 2009
|
40 |
Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension. J Palliat Med 18(7):593-600, 2015
DOI
|
41 |
Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 43(2):306-313, 2012
DOI
|
42 |
Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, Suzuki Y, Narabayashi M, Boku N. Phase IIb, randomized, double blind, placebo-controlled study of naldemedine for the treatment of opioid induced constipation in patients with cancer. J Clin Oncol 35:1921-1928, 2017
DOI
|
43 |
Mori M, Yongli J, Kumar S, Ashikaga T, Ades S. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study. Int J Clin Oncol 22:397-404, 2017
DOI
|
44 |
Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain 154(9):1542-1550, 2013
DOI
|
45 |
Chey WD, Webster L, Sostek M, Lappalainen J, Barkder PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 370:2387-2396, 2014
DOI
|
46 |
Clemens KE, Quednau I, Klaschik E. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. Int J Clin Pract 65:472-478, 2011
DOI
|
47 |
Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain 21:1528-1537, 2017
DOI
|
48 |
Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study. Eur J Pain 21:1485-1494, 2017
DOI
|
49 |
Gao YL, Li LY, Li PW. Clinical study on the effectiveness of Yi-Qi-Run-Chang Method for opioids induced constipation. J Trad Chin Med Emergency 19(4);585-586, 2016
|
50 |
Chung VC, Wu X, Lu P, Hui EP, Zhang Y, Zhang AL, Lau AY, Zhao J, Fan M, Ziea ET, Ng BF, Wong SY, Wu JC. Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis. Medicine (Baltimore) 95(7):e2793, 2016. doi: 10.1097/MD.0000000000002793.
DOI
|
51 |
Chen CM, Lin LZ, Zhang EX. Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin J Integr Med 20(7):496-502, 2014
DOI
|